Skip to main content

Table 4 ORs for T2DM, Pre-T2DM, and hyperglycemia in the outcome survey associated with the high–high group with the low–low group as reference, adjusting for covariates

From: Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study

Independent variable

Outcome

T2DM (37 vs 155)

Pre-T2DM (89 vs 155)

Hyperglycemia (126 vs 155)

OR (95% CI)

p

OR (95% CI)

p

OR (95% CI)

p

Black race

1.14 (0.50–2.63)

0.758

0.98 (0.51–1.90)

0.953

1.07 (0.60–1.91)

0.823

Female sex

0.72 (0.30–1.73)

0.467

0.39 (0.21–0.72)

0.003

0.49 (0.28–0.84)

0.010

Age

1.05 (0.96–1.16)

0.286

1.10 (1.02–1.17)

0.010

1.08 (1.02–1.15)

0.011

BMI

1.07 (1.01–1.12)

0.014

1.09 (1.05–1.14)

< 0.001

1.08 (1.04–1.12)

< 0.001

Smoking

1.74 (0.71–4.25)

0.224

1.17 (0.59–2.32)

0.647

1.28 (0.70–2.34)

0.419

Alcohol drinking

0.30 (0.11–0.86)

0.025

1.06 (0.57–1.96)

0.855

0.77 (0.44–1.36)

0.367

Groupa

2.38 (1.06–5.33)

0.035

2.27 (1.27–4.05)

0.006

2.18 (1.30–3.64)

0.003

  1. High and low levels of baseline hsCRP and follow-up HOMA-IR were defined by their medians
  2. OR, odds ratio; CI, confidence interval; T2DM, type 2 diabetes mellitus; BMI, body mass index; hsCRP, high-sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment for insulin resistance
  3. aCoding: high–high group = 1; low–low group = 0
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840